Profile picture

Doctor Miguel Frias

University hospitals of Geneva, Geneva (Switzerland)
Follow
Logo ESC

Contributor content

HIV-infected patients display increased proatherogenic anti-apolipoprotein A1 autoantibodies, inflammatory and metabolomic markers
Presentation
HIV-infected patients display increased proatherogenic anti-apolipoprotein A1 autoantibodies, inflammatory and metabolomic markers
Read more
Evaluation of antiretroviral therapy on metabolomics and atherogenic markers in HIV patients
Presentation
Evaluation of antiretroviral therapy on metabolomics and atherogenic markers in HIV patients
Read more
The presence of anti-apolipoprotein A1 autoantibodies is associated with a pro-atherogenic profile in HIV-infected patients.
Presentation
The presence of anti-apolipoprotein A1 autoantibodies is associated with a pro-atherogenic profile in HIV-infected patients.
Read more

ESC 365 is supported by

novartis Explore sponsored resources